David Fitzhugh, MD
Allergy & Immunology · Chapel Hill, NCNPI 1962627547
Payments from drug & device makers
Across 415 payments — averaging $249.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$46K
- Genentech USA, Inc.$39K
- Alk-abello, Inc$5K
- Aimmune Therapeutics, Inc.$3K
- GSK$2K
- CSL Behring$2K
- plus $6K from 30 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 111 | $46,429 |
| Genentech USA, Inc. | 59 | $38,936 |
| Alk-abello, Inc | 11 | $4,603 |
| Aimmune Therapeutics, Inc. | 3 | $3,201 |
| GSK | 19 | $1,991 |
| CSL Behring | 36 | $1,967 |
| Takeda Pharmaceuticals U.S.A., Inc. | 12 | $1,391 |
| Biocryst US Sales Co., LLC | 10 | $1,320 |
| Regeneron Healthcare Solutions, Inc. | 22 | $655 |
| Sanofi | 17 | $510 |
| Novartis | 19 | $414 |
| AbbVie | 15 | $413 |
| Amgen | 11 | $348 |
| Grifols USA, LLC | 5 | $183 |
| Optinose US, Inc. | 10 | $172 |
| Blueprint Medicines Corporation | 5 | $159 |
| Organon | 13 | $118 |
| Pfizer | 5 | $107 |
| Pharming Healthcare, Inc. | 5 | $101 |
| Incyte Corporation | 3 | $71 |
| Covis Pharma GmbH | 3 | $53 |
| Kaleo, Inc. | 3 | $45 |
| Biocryst Pharmaceuticals, Inc. | 2 | $38 |
| ARS Pharmaceuticals Operations, Inc. | 2 | $36 |
| Boehringer Ingelheim | 2 | $34 |
| Ionis Pharmaceuticals, Inc. | 1 | $32 |
| ADMA Biomanufacturing LLC | 1 | $24 |
| Regeneron | 2 | $23 |
| Phadia US Inc. | 1 | $21 |
| Octapharma USA, Inc. | 1 | $21 |
| Merck | 1 | $18 |
| Teva Pharmaceuticals USA, Inc. | 1 | $17 |
| Genentech, Inc. | 1 | $17 |
| Arcutis Biotherapeutics, Inc. | 1 | $17 |
| USWM, LLC | 1 | $16 |
| Hikma Pharmaceuticals USA | 1 | $14 |
How this compares
$103,514 in reported general payments places this provider in the 85th percentile of 140 allergy & immunology providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other allergy & immunology in Chapel Hill
- Edwin KimChapel Hill$874K
- Scott ComminsChapel Hill$555K
- Craig LaforceRaleigh$7.9M
- Karen DunnRaleigh$3.3M
- Maeve OconnorCharlotte$2.2M
- David CypcarAsheville$1.6M
- Joel HartmanWinston Salem$749K
- William McCannAsheville$710K
- Cristine RadojicicDurham$558K
- Roopen PatelCharlotte$391K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.